Re-analysis of transcriptomic data from an obesity study [37] supports the notion that ACE2 is more highly expressed in obese persons and declines with weight loss (Supplementary Figure S9). The gene discussed is ACE2; the disease is obesity due to melanocortin 4 receptor deficiency.